H1N1 Influenza-A Virus New Caledonia/20/99 IVR 116
Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/ New Caledonia/20/99 IVR 116. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.
Immunological Functions
Tested with anti-influenza A monoclonal antibodies in ELISA. Serological studies of influenza A virus, immunogen for antibody production.
Inactivation
The product has been treated by thimerosal and beta propiolactone treatment, in a manner consistent with methods of inactivation.
Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required when using the product.
Physical Appearance
Sterile Filtered colorless solution
, The H1N1 A/New Caledonia/20/99 IVR solution contains STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal.
Purity
Greater than 90.0% as determined by ELISA analysis.
Storage
A/New Caledonia/20/99 IVR although stable 4°C for 4 weeks, should be stored desiccated below -18°C. Please prevent freeze-thaw cycles.
